Two fish oil-based grades of Evonik’s omega-3 powder platform AvailOm are now available in Brazil, following approval from the Brazilian health authority ANVISA. Nutraceutical companies and consumers in Brazil can now access Evonik’s AvailOm 50 High EPA and AvailOm 50 High DHA.
“We are proud to now bring both this superior ingredient and our global formulation capabilities to Brazilian consumers, and we look forward to expanding this offering in Brazil and beyond in Latin America,” said Gilles Razzauti, director of Advanced Food Ingredients at Evonik’s Health Care business.
Omega-3 is suitable for dietary supplements tailored to healthy agers, pregnant women, and other consumer groups. AvailOm is produced using the company’s proprietary process to combines free fatty acids with the essential amino acid L-lysine. The complex formed is easy to process into a range of formulations with no fishy aftertaste, the company claims.
The powders are directly compressible into tablets and enable nutraceutical companies to develop differentiated combination products with other active ingredients such as botanicals, vitamins, proteins and minerals for enhanced performance and synergistic benefits.
The AvailOm 50 High DHA variant is a supplement solution designed for use during pregnancy and early motherhood and to support eye function or brain health in later stages of life. The EPA version promotes heart health, joint health and reduces inflammation. All products in the range are reportedly produced from certified sustainable sources to protect marine ecosystems.